1. Measurement of fractional whole-body gluconeogenesis in humans from blood samples using ²H nuclear magnetic resonance spectroscopy
- Author
-
Kunert, O., Stingl, H., Rosian, E., Krssak, M., Bernroider, E., Seebacher, W., Zangger, K., Staehr, P., Chandramouli, V., Landau, B.R., Nowotny, P., Waldhausl, W., Haslinger, E., and Roden, M.
- Subjects
Gluconeogenesis -- Physiological aspects -- Measurement -- Usage ,Nuclear magnetic resonance spectroscopy -- Usage -- Measurement -- Physiological aspects ,Type 2 diabetes -- Development and progression ,Health ,Usage ,Physiological aspects ,Development and progression ,Measurement - Abstract
Several problems limit quantification of gluconeogenesis. We applied in vitro ²H-nuclear magnetic resonance (NMR) spectroscopy to simultaneously measure ²H in all glucose carbons for direct assessment of gluconeogenesis. This method was compared with ²H measurement in carbons 5 and 2 using gas chromatography-mass spectrometry (hexamethylenetetramine [HMT]) and with in vivo [sup.13]C magnetic resonance spectroscopy (MRS). After 14 h of fasting, and following ²[H.sub.2]O ingestion, blood was obtained from nine healthy and seven type 2 diabetic subjects. Glucose was purified, acetylated, and analyzed for ²H in carbons 1-6 with ²H-NMR. Using 5:2 ratios, gluconeogenesis increased (P < 0.05) over time and mean gluconeogenesis was lower in control subjects than in type 2 diabetic patients (63 ± 3 vs. 75 ± 2%, P < 0.01). [sup.13]C-MRS revealed higher hepatic glycogenolysis in control subjects (3.9 ± 0.4 vs. 2.3 ± 0.2 µmol * [kg.sup.-1] * [min.sup.-1]) yielding mean contribution of gluconeogenesis of 65 ± 3 and 77 ± 2% (P < 0.005). Measurement of gluconeogenesis by ²H-NMR correlated linearly with [sup.13]C-MRS (r = 0.758, P = 0.0007) and HMT (r = 0.759, P = 0.0007). In an additional protocol, ²H enrichments demonstrated a fast decline of gluconeogenesis from ~100 to ~68% (P < 0.02) within 4 h of galactose infusion after 40-44 h of fasting. Thus, in vitro ²H-NMR offers an alternative approach to determine fractional gluconeogenesis in good agreement with standard methods and allows monitoring of rapid metabolic alterations. Diabetes 52:2475-2482, 2003, In type 2 diabetic patients, gluconeogenesis primarily accounts for increased endogenous glucose production (EGP) and fasting plasma glucose concentrations (1). Previous methods for measuring gluconeogenesis yielded a wide range of [...]
- Published
- 2003